Association of HSD17B13 rs72613567: TA Allelic Variant With Liver Disease: Review and Meta-Analysis

Abstract AIM: To assess the association of HSD17B13 rs7261356:TA allelic variant with liver disease, we performed the current review and meta-analysis. METHODS: 5 studies were identified by a search of CNKI,CBM,MEDLINE, PubMed, EMBASE, and CENTRAL databases from inception to April 2020. Odds ratios (ORs) with 95% confidence interval (CI) were calculated using random effects model or fixed effects model based on the between-study heterogeneity.The Stata 12.0 software was employed for data analysis.RESULTS: Statistical analysis showed that the HSD17B13 rs7261356:TA allelic variant was associated with HCC compared with CLD (TA vs T OR=0.766, 95% CI=0.682-0.860, P=0.000) or healthy controls(TA vs T OR=0.649, 95% CI=0.431-0.977, P=0.038). But the HSD17B13 rs7261356:TA allelic variant was not associated with NAFLD compared with non-NAFLD(TA vs T OR=0.749, 95% CI=0.517-1.804, P=0.126).Egger’s test revealed no significant publication bias. Conclusion: The present findings suggest HSD17B13 rs7261356:TA allelic variant was association with HCC risk in the entire population studied.